Two Long-Established Independent IRBs Discussing Merger
Independent Review Consulting (IRC) an independent Institutional Review Board (IRB) founded in 1984 announced that it has entered into a preliminary agreement to merge with the Ethical Review Committee (ERC), another central IRB providing reviews of research on behalf of subject safety since 1988. Erica Heath, founder of Independent Review Consulting (IRC), accredited by the Association for the Accreditation of Human Research Protection Program, Inc. (AAHRPP) and located in Northern California is in talks with Terri Majors, President of the Ethical Review Committee (ERC) in Missouri. Under the terms of the proposed merger, the two organizations will begin implementing an integration plan immediately while they continue to operate as their respective organizations. The first phase of the plan will be the formation of Ethical and Independent Review Services (E&I), a new Limited Liability Corporation to provide management services for both entities. Both companies have experience in the review of late-stage, multi- center trials. While IRC specializes in medical devices and federally funded studies, ERC has developed processes specializing in efficient turn-around of large, late-stage multi-center trials.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
